Langerhans cell histiocytosis (LCH) can affect children and adults with a wide variety of
clinical manifestations, including unifocal, single-system multifocal, single-system pulmonary …

Abstract Purpose The frequency of Langerhans cell histiocytosis (LCH) and associated
malignancies (AM) is greater than statistically expected. Here, we analyze LCH-AM co …

Simple Summary Increased oxidative stress (OS) has been implicated as a relevant risk
factor for cancer development and progression. The incidence of differentiated thyroid …

The present study aims to evaluate the characteristics and treatment outcomes of adult
Langerhans cell histiocytosis (LCH) patients with thyroid involvement. We retrospectively …

Background Langerhans cell histiocytosis (LCH) is a rare disease caused by the clonal
expansion of CD1a+/CD207+ LCH cells. The thyroid involvement in LCH has mostly been …

Purpose. This study aims to explore the application value of the 18F‐FDG PET/CT imaging
in diagnosing, staging, and typing Langerhans cell histiocytosis (LCH) via the morphological …

Purpose Langerhans cell histiocytosis (LCH) is a rare clonal disorder of Langerhans antigen-
presenting cells. However, thyroid LCH involvement is relatively rare. We present the first …

Langerhans cell histiocytosis (LCH) is characterized by clonal proliferation of specific
dendritic cells and involves many organs and systems, such as the lungs, skin, bone, liver …

Langerhans cell histiocytosis (LCH) is a clonal neoplasm of myeloid dendritic cells, rarely
involving the thyroid gland. Papillary thyroid carcinoma (PTC) is the most common …

Interventions: VP regimen (vincristine, dexamethasone per os) and related supportive
treatments were given as inducing chemotherapy for 6 weeks. Outcomes: After the second …